PROJECT 4 - Vif (PETERLIN AND GROSS. PROJECT LEADERS)The viral infectivity factor Vif is an essential accessory protein of primate lentiviruses, HIV-1, HIV-2,and SIV. Without Vif, these viruses do not replicate in non-permissive cells or in the host. Vif inactivatesthe cellular cytidine deaminases ASF and A3G, which are members of the APOBEC3 (apolipoprotein BmRNA-editing enzyme catalytic-polypeptides 3) family. In the absence of Vif, these APOBEC3 proteinsare incorporated into new viral particles where they deaminate cytidines in the minus-strand cDNA duringreverse transcription. These DNA lesions result in viral DNA degradation or introduction of deleteriousmutations. In addition, the APOBEC3 proteins can inhibit viral replication in the absence of their enzymaticactivity, possibly by altering the reverse transcription process itself. Thus, APOBEC proteins protect cellsagainst HIV, and Vif has evolved to provide an essential viral counter defense.A key role for Vif is to promote ubiquitination and subsequent destruction of A3G and ASF by theproteosome. Vif recruits A3G and ASF to a cellular ubiquitin protein ligase that includes Cullin-5, Ring-box2, and Elongins B and C (EloBC). Even modest inhibition of Vif function, either by interfering with bindingto A3G and/or ASF or by blocking recruitment of the EloBC/Cul5/Rbx2 E3 ligase, might significantly reduceHIV-1 loads in vivo. Therefore, a major objective of this project is to determine the architecture of theVif/EloBC/Cul5/Rbx2 complex and subcomplexes with A3G.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
1P50GM082250-01
Application #
7480039
Study Section
Special Emphasis Panel (ZRG1-AARR-A (40))
Project Start
2007-09-01
Project End
2012-07-31
Budget Start
2007-09-01
Budget End
2008-07-31
Support Year
1
Fiscal Year
2007
Total Cost
$412,682
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chen, Si-Han; Jang, Gwendolyn M; Hüttenhain, Ruth et al. (2018) CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. EMBO J 37:
Leoz, Marie; Kukanja, Petra; Luo, Zeping et al. (2018) HEXIM1-Tat chimera inhibits HIV-1 replication. PLoS Pathog 14:e1007402
Cheng, Yifan (2018) Single-particle cryo-EM-How did it get here and where will it go. Science 361:876-880
Roth, Theodore L; Puig-Saus, Cristina; Yu, Ruby et al. (2018) Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559:405-409
Ferdin, Jana; Gori?ar, Katja; Dolžan, Vita et al. (2018) Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA. PLoS One 13:e0191613
Cheng, Yifan (2018) Membrane protein structural biology in the era of single particle cryo-EM. Curr Opin Struct Biol 52:58-63
Ivry, Sam L; Meyer, Nicole O; Winter, Michael B et al. (2018) Global substrate specificity profiling of post-translational modifying enzymes. Protein Sci 27:584-594
Cary, Daniele C; Peterlin, B Matija (2018) Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1. PLoS One 13:e0208055
Palovcak, Eugene; Wang, Feng; Zheng, Shawn Q et al. (2018) A simple and robust procedure for preparing graphene-oxide cryo-EM grids. J Struct Biol 204:80-84
Tambe, Akshay; East-Seletsky, Alexandra; Knott, Gavin J et al. (2018) RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a. Cell Rep 24:1025-1036

Showing the most recent 10 out of 199 publications